Amerigo Scientific launched a comprehensive portfolio of GMP-grade proteins tailored to accelerate the development and clinical translation of cell therapies. NEW ...
Commercial launch of AlbuFree™ DX recombinant human albumin by Proliant Health & Biologicals using Dyadic’s production ...
FDA granted Breakthrough Therapy Designation for AAV2-hAQP1 for the treatment of Grade 2 and Grade 3 late xerostomia caused by radiotherapy for cancers of the upper aerodigestive tractMeiraGTx to hold ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai"), a human-centered global leading research-based ...
Then, roughly 12,500 years ago, it vanished entirely.
Commercial launch of AlbuFree DX recombinant human albumin by Proliant Health & Biologicals using Dyadic's production platform, with Dyadic eligible to receive a share of profits from product salesExp ...
Q4 2025 Earnings Call March 25, 2026 5:00 PM EDTCompany ParticipantsPing Rawson - Chief Financial OfficerJoseph Hazelton ...
ASX gains (just) in volatile hump-day trade, swinging between -0.14% and +0.24% Info tech and energy stocks lead gains Breadth strong with seven sectors and 124/200 stocks rising The S&P/ASX 200 is ...
Twenty-seven children died in a Texas flood, dividing families over whether it was an act of God or adult failure.
IND Filing and Concurrent RMAT Request Position XytriX™ as a Potential Breakthrough Biotherapeutic for More Than 500 ...
Q4 2025 earnings call: commercialization shift, new recombinant product launches, partners, 2026 revenue outlook & cash runway.
On this "Face the Nation with Margaret Brennan" broadcast, Border Czar Tom Homan and former U.S. Surgeon General Jerome Adams join Margaret Brennan.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results